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ABSTRACT 
 
The objective of this study was to determine the effects of injectable and oral arginine 
(Arg) supplementation provided 14 d post-breeding on reproductive performance of fall lambing 
ewes.  Upon estrus detection (d 0) ewes were randomly assigned to one of six treatments for a 
14-d treatment period: injectable saline (CON; n = 25), injectable alanine (IVALA; n = 20), 
injectable arginine (IVARG; n = 23), oral rumen-protected Arg (RPARG; n = 20), oral soybean 
meal (SBM; n = 23), or oral fishmeal (FM; n = 24). Weaning rates were higher (P < 0.05) in Arg 
supplemented ewes. Plasma progesterone and serum Arg concentrations exhibited a treatment 
and day effect (P < 0.05), but no treatment × day interaction was observed (P > 0.05). In contrast 
to previous research, supplemental Arg during the first 14 d of pregnancy did not improve 
pregnancy or lambing rates, however, IVARG positively impacted weaning rates.  
Key Words: arginine, progesterone, reproduction, sheep  
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
Introduction 
Breeding sheep inventory in the United States on January 1, 2014 totaled 3.88 million 
head, down 2 % from 2013 [National Agriculture Statistics Service (NASS), 2014]. Current 
reproduction research in sheep has focused primarily on increasing lamb production by 
increasing the number of lambs born per ewe, therefore increasing potential returns for the 
producer. However, the 2013 U.S. lamb crop totaled 3.37 million head, down 2% from 2012, 
with a weaning rate of 107 lambs per 100 ewes one year or older, also down 2 % from the 
previous year (NASS, 2014). With this in mind, new research should be focused on a feasible 
resolution to increase reproductive efficiency in sheep. 
Past studies conducted in early-life nutrition in sheep began in the 1970s and were 
focused on the early neonatal period and the latter part of pregnancy. These time periods were 
chosen because the nutrient demands on the fetus are highest at these stages of reproduction 
(Robinson et al., 1983). Sensitivity to nutritional status was observed by Parr et al. (1992), who 
reported that ewes fed two times their maintenance requirements after breeding had a pregnancy 
rate of 48%, while those ewes fed rations calculated to maintain live weight or fed half the 
maintenance ration during this same time had pregnancy rates ranging from 60 to 68%. These 
findings showed correct nutritional status is essential in early pregnancy, especially in the time 
before the conceptus is present in the uterus or d 13 of pregnancy, if lifespan of the CL is to be 
extended beyond d 14 (Moor et al., 1960).  Thus, d 14 is when maternal recognition occurs 
(Moor et al., 1960). Previous research has indicated if maternal blood flow can be increased to 
the conceptus prior to maternal recognition of pregnancy (d 14), embryonic loss might be 
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decreased (Luther et al., 2009; Saevre et al., 2011a). However, information concerning the 
underlying mechanisms that effect embryonic loss in large animal species is largely lacking.  
Embryonic and fetal deaths during pregnancy account for 25 to 50% of the total number 
of fertilized ova in the ewe (Knights et al., 2003; Dixon et al., 2007). The majority of embryonic 
loss has been reported to occur before d 18 (Hulet et al., 1956; Moore et al., 1960; Quinlivan, 
1966). However, Dixon et al. (2007) reported that 19.9% of ewes experience late embryonic loss, 
fetal loss, or both; and 21.2% of the embryos or fetuses were lost from d 25 to term.  In multiple 
birth type pregnancies, loss of individual embryos or fetuses can occur without a total loss of 
pregnancy (Rhind et al., 1980; Schrick and Inskeep, 1993). Additionally, a small percentage of 
embryos are inherently non-viable in the ewe (Wilmut et al., 1986), which would suggest that a 
proportion of early embryonic losses could be prevented. A better understanding of preventing 
embryonic loss would provide a method to increase livestock productivity.  
Recently, low circulating concentrations of progesterone, estrogen, and vascular 
endothelial growth factor in the ewe have been identified as factors affecting prenatal losses 
(Dixon et al., 2007). These factors are important for optimizing the uterine environment and 
ensuring proper development of the placenta during early pregnancy (Nephew et al., 1991; 
Spencer et al., 2004).     
The amino acid L-arginine (Arg) is important for the synthesis of polyamines and nitric 
oxide, both of which are essential for proper development of the embryo and placenta. Gestating 
sows supplemented with Arg achieved a 22% increase in live piglets born (11.4 vs. 9.4, P < 0.03, 
respectively; Mateo et al., 2007).   Furthermore, pregnant rats supplemented with 1.3% Arg-HCl 
throughout pregnancy or between d 1 and 7 of gestation had increased embryonic survival and 
litter size by 30% (Zeng et al., 2008). It is reasonable to hypothesize that supplementation with 
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Arg would have beneficial impacts on optimizing the uterine environment for ensuring early 
embryonic survival in sheep. 
The most important factor effecting success of most commercial sheep operations is 
reproductive efficiency (Lupton, 1998); however, it is also one of the most difficult factors to 
improve. Currently, the sheep industry is focused on the need for improved reproductive 
efficiency by increasing the number of lambs born per ewe while improving the growth 
efficiency of those offspring. New advancements in animal science research offer the possibility 
for significant improvements in efficiency of lamb production. 
Reproduction in the Ewe 
 Sheep are one of many mammals that have synchronized reproductive activity, which is 
coordinated by changes in length of day (Woodfill et al., 1991; Malpaux et al., 1996; Barrell et 
al., 2000).  These seasonal patterns of reproduction are coordinated to allow parturition to occur 
in spring months, which commonly produce more and higher quality forage that increases the 
likelihood for offspring to thrive. Most sheep breeds exhibit a short day breeding pattern when 
located in mid to high latitudes, shifting parturition’s occurrence to the spring of the year, 
allowing offspring to grow and develop during summer months while availability of forage is 
increased and weather is optimal before declining into the winter season. However, in sub- 
tropical and tropical environments, there is a tendency for ewes to breed throughout the year with 
forage quality being the main controlling factor in breeding activity (Rosa and Bryant, 2003). 
Seasonality in sheep is controlled by multiple environmental cues, including photoperiod and 
geographic location (Vivien-Roels and Pévet, 1983). 
 The main environmental cue controlling seasonality in sheep is photoperiod via neural 
and humoral processes (Malpaux et al., 1996). As light enters the retina of the eye, presynaptic 
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neurons are stimulated in the suprachiasmatic nucleus; this stimulation sends signals to the 
superior cervical ganglion initiating the firing of the postganglionic neurons (Senger, 2005). The 
message regulates melatonin secretion by the postganglionic neurons synapse along with 
inhibitory neurons connecting with pinealocytes (Malpaux et al., 1996; Senger, 2005). During 
short photoperiods, signal transmission is decreased, which decreases the inhibition on the pineal 
gland and increases the amount of melatonin released. The activity of the hypothalamo-
hypophyseal and gonadal axis is regulated by the duration of melatonin secretion (Karsch et al., 
1989). Melatonin then stimulates the release of gonadotropin releasing hormone, or GnRH.  
Ewes are considered to be polyestrus and usually exhibit an estrous cycle every 17 d 
during the fall of the year (Schillo, 2009). The estrous cycle is divided into four stages: estrus, 
metestrus, diestrus and proestrus. These are then grouped into two main phases: the follicular 
phase and luteal phase. During the follicular phase, the CL or corpora lutea regresses and 
ovulation occurs, thus including proestrus and estrus. The luteal phase, including metestrus and 
diestrus, is described as the time from ovulation to the time of regression of the CL.  
Maternal Recognition of Pregnancy 
In order for normal development and differentiation of the embryo to occur, 
communication between the embryo and maternal system must be established following 
conception. Maternal recognition of pregnancy occurs at approximately d 13 following 
conception. The migration of the embryo has been reported to occur between d 12 and 14 of 
gestation in the ewe with attachment of the trophoblast occurring at d 16 to 17 (Nephew et al., 
1989). The synthesis of estradiol is closely associated with the intrauterine migration of embryos 
(Nephew et al., 1989). Proper development of the embryo initially depends on the maternal and 
paternal genes. When the conceptus elongates from blastocyst to the filamentous form, interferon 
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tau (IFN) is produced, which is responsible for the antiluteolytic signal for the recognition of 
pregnancy (Spencer and Bazer, 2002). The maintenance of the CL, the primary structure 
responsible for progesterone production during early pregnancy, is allowed only because of the 
presence of IFN, which also inhibits the pulsatile production of PGF2 (Bazer et al., 1998). The 
major protein, IFN, is secreted by the trophectoderm of the peri-implantation conceptus 
between d 10 and 21 of pregnancy in sheep (Bazer et al., 1998). The concentration of IFN 
increases around d 12 to 13 as the embryo takes on a more filamentous shape. This indicates that 
IFN is important in the recognition of pregnancy along with progesterone and its suppression of 
PGF2.  
Progesterone is also necessary for the secretion of histotroph by the uterine glands, which 
helps nourish the conceptus during the peri-implantation period (Spencer et al., 2004). 
Histrotroph contains enzymes, growth factors, cytokines, lymphokines, hormones and transport 
proteins (Spencer et al., 2004), all of which have been shown to ensure proper development and 
survival of the embryo in humans (Burton et al., 2002), primates (Bazer et al., 1979; Roberts and 
Bazer, 1988; Carson et al., 2000; Gray et al., 2001a) and sheep (Lawson et al., 1983; Flechon et 
al., 1986; Gray et al., 2001b; Gray et al., 2002).  
Reproductive Loss in the Ewe 
Reproductive loss accounts for one of the largest economic inefficiencies in any livestock 
operation, although often unnoticed (Bradford and Meyer, 1986). The majority of prenatal loss 
occurs before d 18 of gestation (Hulet et al., 1956; Moore et al., 1960; Quinlivan, 1966). Early 
development could also play a role in altering losses later in gestation. For example, epigenetics 
caused by events such as adverse uterine environment or poor maternal nutrition status 
(Bloomfield, 2011). As stated previously, research by Dixon et al. (2007) reported that 
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approximately 19.9% of all ewes experience late embryonic loss, fetal loss, or both; and 21.2% 
of the embryos or fetuses were lost from d 25 to term. Loss of individual embryos can occur 
without a complete loss of pregnancy, such as in the case of multiple fetuses (Rhind et al., 1980; 
Schrick and Inskeep, 1993).  
It has been reported that 30% of fertilized ova in sheep are not represented by live births, 
resulting in frequent, but unrecognized as a form of flock production loss (Bolet, 1986; Knights 
et al., 2003; Dixon et al., 2007). Some research has concluded that the majority of embryonic 
loss in the ewe occurs around the time of maternal recognition of pregnancy (Cross, 2001). 
Prenatal loss in the ewe has also been linked to abnormal circulating concentrations of 
progesterone, estrogen and vascular endothelial growth factor (Dixon et al., 2007). Strategies to 
enhance prenatal growth and survival could clearly have a major economic impact in the sheep 
industry.  
Functions of Arginine 
  Arginine is an essential amino acid for young, growing mammals and carnivores and 
conditionally indispensable for young ruminants (Ball et al., 2007). Requirements for Arg are 
increased in the neonate and necessary to promote postnatal growth and development; however, 
as development progresses, the need decreases. The small intestine is a major source of 
circulating citrulline for endogenous synthesis of Arg in the rat (Windmueller and Spaeth, 1981). 
Arginine was also identified as a precursor for nitrite/nitrate synthesis and nitric oxide (NO), 
which is the endothelium-derived relaxing factor essential for vascular tone and hemodynamics 
(Wu and Morris, 1998; Figure 1.1). Below is a listing of the many functions and pathways of Arg 
synthesis and metabolism: 
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 Nitric oxide was identified as the active intermediate of the Arg/NO pathway in 
macrophages and endothelial cells (Wu and Morris, 1998).   
 Citrulline is converted to Arg in the kidney via Argininosuccinate synthase (ASS) 
and Argininosuccinate lyase (ASL; Wu and Knabe, 1995). Enzymes ASS and 
ASL convert citrulline to Arg in the cytosol. 
 Glutamine and citrulline decrease when there is a decrease in phosphate-
dependent glutaminase (PDG), pyrroline-5-carboxylate synthase (P-5-C) and 
carbamoyl phosphate synthase I (CPS I). Enzymes PDG, P-5-C, ornithine 
carbamoyltransferase (OCT), and CPS I catalyze citrulline formation from 
glutamine in the mitochondria. 
 The conversion of citrulline to Arginine decreases with a decrease of ASS and 
ASL.  
 Glutamine serves as major fuel source for neonatal pig enterocytes and provides 
all carbon and nitrogen molecules for Arg synthesis.  
 The synthesis of Arg from glutamine involves two portions of enterocyte cells, 
the mitochondria and cytosol. The process involves many enzymes including: 
PDG, P-5-C, ornithine aminotransferase (OAT), OCT, CPS I, ASS and ASL. 
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However, the pig is the only species of mammal to release endogenously synthesized Arg 
into venous circulation.  Sixty percent of the net synthesized Arg in adult mammals occurs in the 
kidney within proximal convoluted tubules; whereby, citrulline is transferred to Arg via ASS and 
ASL. This is limited by the amount of citrulline produced by the small intestine (Osowska et al., 
2004).  
Figure 1.1. Arginine metabolism in mammals. Reprinted from Biomedicine and 
Pharmacotherapy (Flynn et al., 2002). 
  
 Argininase is the enzyme required for regulatory availability of Arg and for the synthesis of 
NO, polyamines, proline and glutamate. Type I Argininase is a cytosolic enzyme expressed in 
high concentrations in the liver as part of the urea cycle. Within the urea cycle it detoxifies waste 
nitrogen in the liver (Wu and Morris, 1998). Type II Argininase is a mitochondrial enzyme, 
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which is expressed in the kidney, brain, small intestine, mammary gland and macrophages (Wu 
and Morris, 1998). Argininase competes for Arg for synthesis of NO. At high levels of 
Argininase the amount of needed Arg is limited for NO synthesis by cells. Argininase is also 
important for wound healing. Polyamines, which are critical for cell proliferation and 
differentiation, are synthesized from ornithine via ornithine decarboxylase (ODC) and argininase 
(Wu and Morris, 1998). When levels of argininase are decreased, no proliferation occurs. In 
newborns, levels of argininase activity are low in the enterocytes; therefore, the amount of 
proliferation from polyamine synthesis in the small intestine is decreased (Wu and Morris, 
1998). However, its activity increases with age along with polyamine synthesis. This increase is 
due in part to glucocorticoid introduction.  
 Proline (Pro) is a major product of Arg catabolism in the enterocyte of post-weaning pigs 
(this varies with age and species), but is virtually undetectable in newborns (Wu, 1997). Proline 
is an essential dietary amino acid for the neonatal piglet, but the requirement decreases with level 
of age and development (Wu, 1997). Proline synthesis in the mammary gland is regulated by 
argininase activity. This enzyme is required for the synthesis of Pro from Arg along with OAT 
and P-5-C reductase. Output of Pro in milk exceeds uptake of Pro by lactating mammary gland, 
although Arg uptake exceeds output. The level of Pro produced is dependent on Arg levels rather 
than glutamate due to the absence of P-5-C synthase. This process does however provide a 
substrate for glutamate synthase. Arginine decarboxylase, found in the brain, liver, kidney, 
adrenal gland, macrophages and the small intestine; however, in the mitochondria it is 
responsible for the production of carbon dioxide and agmatine (a product of decarboxylation and 
intermediate of polyamine synthesis) from Arg (Wu, 1997).  
 10 
 
 Nitric oxide and the enzyme NO synthase both play a role in steroidogenesis, ovulation, 
embryo implantation and maintenance of pregnancy (Gouge, 1998; Manser, 2004). Nitric oxide 
relaxes vascular smooth muscle and is produced by endothelial cells (Ignarro et al., 1987). Nitric 
oxide synthesis is the result of the oxidation of Arg to citrulline by NO synthase (Figure 1.1). 
Nitric oxide synthase play a regulatory role in Arg degradation to NO. The enzymes are 
regulated by a Ca2+/calmoduline feedback mechanism (Ignarro et al., 1987). Relaxation of 
vascular smooth muscle is caused by the activation of the cyclic guanosine monophosphate 
pathway (Moncada and Higgs, 1993). During pregnancy in rodents, inhibition of NO synthase 
expressed higher incidence of embryonic mortality (Chwalisz et al., 1999). Arginine 
supplemented pigs exhibited a 22% increase in the number of live piglets born (Mateo, 2007). 
Zeng (2008) reported that Arg increased embryonic survival and litter size in rats by 30% 
whether supplemented throughout or between d 1 and 7 of pregnancy with 1.3% Arg HCl. 
Arginine treatment in late pregnancy increases transport of nutrients to the unborn lamb 
(Thureen, 2002), enhances fetal protein levels in sheep, and increases lamb BW at birth (De Boo, 
2005).  
 Arginine plays an essential role in the synthesis of polyamines (Table 1.1). Polyamines are 
essential for cell growth and differentiation, including spermatogenesis. In pigs, 1% Arg HCl 
was given to sexually active boars for 30 d and although it had no effects on semen volume, Arg 
and polyamine concentrations were increased (43 and 63%, respectively; Wu et al., 2009). Wu et 
al. (2009) also reported sperm concentrations increased by 18% and motility by 8%. In rats fed 
an Arg-free diet, an increase in fetal reabsorptions, intrauterine growth retardation, increase in 
embryonic loss and a decrease in number of live fetuses born was observed (Greenburg et al., 
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1997). Arginine given to rats via drinking water prevented hypoxia-induced fetal growth 
retardation (Vosatka et al., 1998). 
 
 
Supplementation of Arginine 
 Wu et al. (1998) stated that Arg is a dispensable (non-essential) amino acid for healthy 
adult humans, but is essential for young, growing mammals and carnivores, along with being 
conditionally essential in adult humans and other animals, particularly in cases of disease or 
trauma. Wu et al. (1998) reports that in adult animals the majority of endogenous Arg synthesis 
involves an inter-organ pathway, in which the small intestine releases citrulline into the blood 
circulation, which is then extracted primarily by the kidney for conversion to Arg. However, Arg 
synthesis and fluxes are underestimated and not completely understood in many tissues. For 
example, the high rates of Arg flux within the urea cycle in the liver are virtually invisible in 
most studies of plasma Arg flux. The ovine placenta contains a high amount of arginase activity 
(Kwon et al., 2004) that would catabolize Arg. The placental transfer of citrulline and its storage 
in allantoic fluid provide an effective strategy to conserve Arg in the ovine conceptus (Wu et al., 
Table 1.1.  Roles of Arginine in reproduction. Adapted from Wu et al., 2009 
Roles of Arginine on reproduction Effect Mediators 
Embryo implantation, survival and 
growth 
Increase Nitric oxide, polyamines and 
protein synthesis 
Fetal survival, growth and health Increase Nitric oxide, polyamines and 
protein synthesis 
Ovulation, ovarian steroidogenesis and 
oocyte quality 
Increase Nitric oxide and polyamines 
Placental angiogenesis, growth and 
function 
Increase Nitric oxide, polyamines and 
protein synthesis 
Spermatogenesis, sperm quality and 
male fertility 
Increase Nitric oxide, polyamines and 
protein synthesis 
Uterine contractility and preterm labor Decrease Nitric Oxide 
Erectile dysfunction Decrease Nitric Oxide 
Preeclampsia in human pregnancy and 
animal models 
Decrease Nitric Oxide 
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2006). During the first half of pregnancy, when the growth of the placenta is most rapid, there is 
an unusual abundance of the Arg-family of AA in fetal fluids of the ovine and porcine (Kwon et 
al., 2003a, 2004; Self et al., 2004; Wu et al., 2005). These findings illustrate the crucial roles of 
Arg-dependent pathways in conceptus growth and development in two diverse species models 
(Wu et al., 2006). Wu et al. (2004) noted that studies in pregnant pigs and sheep indicated 
impaired synthesis of NO and polyamines in the conceptuses of underfed and overfed dams. 
Dietary protein deficiency reduced the availability of Arg and ornithine in maternal plasma, fetal 
plasma, amniotic fluid, and allantoic fluid as well as placental synthesis of NO and polyamines 
in pregnant pigs (Wu and Morris, 1998; Wu et al., 1998), with similar results in underfed ewes 
(Kwon et al., 2004).  
 Previously, Arg has been provided through injection or supplemented in the feed. However, 
with ruminant species, protein is predominately degraded in the rumen; therefore, not allowing 
specific nutrients such as Arg to reach the small intestine at similar concentrations to the feed for 
absorption.  
Injectable Arginine 
Thureen et al. (2002) showed that Arg injections during late pregnancy in ewes increased 
transport of nutrients to the fetus, while De Boo et al. (2005) reported enhanced lamb birth 
weight with injections of Arg during late gestation. In a trial conducted by Luther et al. (2009), 
ewes receiving injectable Arg from the time of standing estrus to d 12 of pregnancy lost fewer 
embryos during early pregnancy and ultimately gave birth to more lambs per ewe. In this trial, 
Arg appeared to enhance early uterine environment, making it more ideal for embryonic survival 
with increased levels of progesterone. Lassala et al. (2011) reported ewes with multiple fetuses 
provided with injectable Arg between d 100 and 121 of gestation had reduced percentage of 
lambs born dead (23%) and an increased percentage of lambs born alive (59%). Lassala et al. 
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(2011) also found that birth weights of quadruplet lambs were enhanced by 23% when ewes 
were given injectable Arg without affecting maternal BW; furthermore, improved pregnancy 
outcome was associated with the increase in maternal plasma concentrations of Arg, ornithine, 
cysteine, and proline, as well as a decrease in circulating levels of ammonia and β-
hydroxybutyrate. Lassala et al. (2010) evaluated an ovine intrauterine growth restriction (IUGR) 
model to test the hypothesis that parental administration of L-Arg is effective in enhancing fetal 
growth. Beginning on d 28 of gestation, ewes were fed a diet providing 100% (CON) or 50 % 
(underfed) of NRC-recommended nutrient requirements. Between d 60 of gestation and 
parturition underfed ewes received IV injections of saline or 155 µmol Arg-HCl/kg BW 3 times 
daily; whereas, control-fed ewes received only saline. The birth weights of lambs from saline-
infused underfed ewes were 23% lower than those of lambs from control-fed dams. 
Administration of Arg to underfed ewes increased concentrations of Arg (69%), ornithine (55%), 
proline (29%), and methionine (37%) in maternal serum and enhanced birth weights of lambs by 
21% compared with saline-infused underfed ewes. These results indicate that parenteral 
administration of Arg to underfed ewes prevented fetal growth restriction and provide support 
for its clinical use to alleviate IUGR in humans. 
Saevre et al. (2011a) also studied the effects injectable Arg in pregnant ewes when 
supplemented from d 9 to 14 post-estrus. In this study, the authors report that ewes injected with 
Arg had greater pregnancy rates, increased circulating serum Arg and ornithine concentrations, 
along with elevated vascular resistance in peripheral blood flow. However, differing from other 
trials, Saevre et al. (2011a) found that ewes given injectable Arg had lower concentrations of 
progesterone relative to the control ewes on d 9 and 10 of gestation, but were similar for the 
remaining treatment period. Since Arg treated ewes had greater pregnancy rates in this trial 
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compared to the control ewes, progesterone levels were not believed to be low enough to lead to 
embryonic loss as observed by Dixon et al. (2007). 
Supplemental Arginine in the Diet to Monogastrics 
 Supplemental Arg, when given to sows in the diet from d 30 of gestation until d 110, has 
been reported to increase the number of live piglets born per sow (Mateo et al., 2007); most 
likely due to an increase in nutrient delivery to the developing embryo. Piglets born to Arg 
supplemented sows in the trial by Mateo et al. (2007) also had increased live litter birth weights 
when compared to the control group sows. At d 90 and 110 of gestation, sows supplemented with 
Arg had lower plasma urea nitrogen concentrations than control gilts (Mateo et al., 2007).  A 
tendency for decreased plasma urea nitrogen concentrations in Arg supplemented animals have 
been observed in other trials (De Boo et al., 2007; Mateo et al., 2008; Zeng et al., 2008). Mateo 
et al. (2007) reports that Arg supplementation may reduce whole-body amino acid degradation 
and, thus, urea production as well as the endogenous synthesis of glutamine from branched-chain 
amino acids and ammonia. In rats supplemented Arg between d 1 and 7 of gestation, Zeng et al. 
(2008) observed increased litter size in response to Arg throughout pregnancy and a greater 
number of surviving embryos. Zeng et al. (2008) stated that these results indicate that dietary 
Arg supplementation enhances embryonic survival; therefore, increasing litter size by 30% at 
term birth and supports implications for enhancing reproductive performance in mammals.  
Injectable or Dietary Alanine 
 Many of the previous trials have used injectable or dietary alanine as an isonitrogenous 
control for Arg treatments (Mateo et al., 2007 and 2008; Zeng et al., 2008). Although plasma 
concentrations of alanine were increased in the supplemented animals in all trials, the 
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reproductive performance was similar to that of the non-supplemented animals; therefore alanine 
had no adverse or beneficial effect on reproductive performance (Mateo et al., 2007).  
Rumen-Protected Amino Acids 
 An interest in ruminally-protected amino acids began with the identification of Lys and 
Met as two of the most limiting amino acids for protein synthesis in ruminants (NRC, 2001). One 
of the main challenges in diet formulation, particularly for animals requiring higher RUP diets, is 
to achieve the desired concentrations of essential amino acids in MP by relying solely on feed 
protein requirements (NRC, 2001). Technologies are currently being developed to allow amino 
acids, such as Met and Lys, to escape ruminal degradation without compromising their 
digestibility in the small intestine.  
 Methods that have been evaluated for protecting free amino acids from ruminal degradation 
have been reviewed (Loerch and Oke, 1989; Schwab, 1995). Currently, there are two categories 
of technology for ruminally protected amino acids: (1) surface coating with a fatty acid/pH-
sensitive polymer mixture, or (2) surface coating or matrices involving fat or saturated fatty acids 
and minerals. The first technological approach of rumen-protected amino acids has the best 
bioavailability (NRC, 2001).   
Rumen-Protected Arginine 
 Peine et al. (2013) conducted a study evaluating the effects of rumen-protected Arg 
supplementation during gestation in ewes on postnatal offspring performance. The ewes were 
first confirmed pregnant and assigned to one of three treatments: control, restricted, and 
restricted with a rumen-protected arginine supplement. On d 54 of gestation, control ewes were 
fed a diet formulated to meet 100% NRC requirements, restricted ewes were fed 60% of 
controls, and the Arg supplemented group received a granular Arg supplement at 180 mg/kg BW 
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daily. Rumen protected Arg supplements were mixed with 49.9 g of corn and fed once a day. At 
lambing, lambs were not permitted to nurse and administered artificial colostrum and then 
provided milk replacer and creep. Body weights of lambs from restricted and restricted with Arg 
supplement ewes were similar at birth, weighing less than lambs from control ewes. By d 19, 
lambs from restricted with Arg supplement ewes weighed more than lambs from restricted ewes, 
and were similar to weights of lambs from control ewes.  
 Saevre et al. (2011b) studied the effects rumen-protected Arg supplementation from d 8 to 
d 13 of the estrous cycle on ewe serum-amino-acid concentration, circulating progesterone, and 
ovarian blood flow.  Ewes were placed on one of four treatments: 0 (CON), 90 mg/kg BW 
supplemental Arg (90 ARG), 180 mg/kg BW supplemental Arg (180 ARG) and 360 mg/kg BW 
supplemental Arg (360 ARG). Ewes were individually fed their respective treatment blended 
with 150 g ground corn, which was immediately followed by 650 g of a pelleted diet. Ewes that 
were fed 360 ARG generally had greater serum-Arg concentrations than CON, 90 ARG, and 180 
ARG on d 11 and d 12. On d 11, arginine as a percent of total amino acid concentration was 
greater in 360 ARG compared with CON and 90 ARG. Total essential amino-acid concentration 
was elevated in 360 ARG compared with 90 ARG and 180 ARG on d 12. Arginine 
supplementation increased peak systolic velocity in the corpus luteum (CL) for 360 ARG and 90 
ARG compared to CON. Supplemental rumen-protected Arg had no effect on serum 
concentration of progesterone. This trial indicated that when rumen-protected Arg is 
supplemented to ewes at the rate of 360 mg/kg BW might increase circulating serum Arg 
concentration, in addition to increasing ovarian blood flow. 
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Feedstuff Composition and Degradability 
 In addition to “artificially” protecting amino acids from ruminal degradation through a 
coating, “naturally” occurring bypass proteins may provide a source of Arg to the small intestine 
of ruminants. Hussein and Jordan (1991) have investigated feeding fishmeal compared to other 
protein sources to determine the extent of ruminal protein degradation, amount of feed protein 
available for ruminal microbes, and intestinal digestion by the host animal. Hussein and Jordan 
(1991) reported that in situ, FM had a slower rate of digestion and N digestion when compared to 
SBM and corn. Davenport et al. (1990) concluded that inclusion of fishmeal in a diet of ground 
soybean meal increased plasma concentrations of arginine along with related amino acids, 
ornithine, and citrulline with 70% of protein in fishmeal escaping ruminal degradation (Mercer et 
al., 1980). Tamminga (1982) stated that fishmeal is a valuable source of protein for growing 
ruminants due to its high protein content, ruminal stability, and amino acid profile. O’Mara et al. 
(1997) investigated amino acid composition of many feedstuffs including fishmeal and soybean 
meal, observing that ruminant feeding systems are constrained by limited knowledge of the 
amino acids absorbed from the small intestine and the amino acid profile of the absorbed fraction 
of bypass protein can be different from the original feed, which could make predictions of 
absorbed amino acids difficult. O’Mara et al. (1997) reported that fishmeal samples had between 
72.9 and 83.6% amino acid nitrogen while soybean meal and sopralin samples had similar amino 
acid nitrogen with 76 and 73%, respectively. O’Mara et al. (1997) also indicated that sopralin 
had no differences in the amino acid profile before or after 8 or 12 h of ruminal incubation and 
was also minimal in fishmeal samples. It was also reported that Arg was one of the more 
susceptible amino acids to ruminal degradation and was lower in proportion in all the feedstuff 
residues than in the original feedstuffs (O’Mara et al., 1997). Interestingly, O’Mara et al. (1997) 
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observed that Arg had increased disappearance postruminally following 12 h of ruminal 
incubation in fishmeal samples and the sopralin sample (27.3, 25.3, and 22.4 g/kg DM of original 
feedstuff; respectively) when compared to soybean meal, rapeseed meal, cottonseed meal, corn 
distillers grain, and corn gluten feed (10.6, 4.9, 13.3, 4.6, 1.4 g/kg DM of original feedstuff; 
respectively). Although more research needs to be done to elucidate RUP and MP along with 
amino acid composition of feeds, the previous results are very useful for applying to the current 
research. Fishmeal withstood ruminal incubation to a greater extent than soybean meal not 
treated with formaldehyde, allowing for more amino acids, including Arg, to be absorbed and 
utilized in the small intestine.  
Conclusion 
 Results from previous research indicate Arg supplementation can have many positive 
effects on reproductive efficiency in ewes, especially when in a compromised status, and lamb 
performance. However, previous research has almost always occurred in a compromised 
situation for the ewe, in most cases on a restricted nutrient intake. In other cases, out of season 
breeding with estrus induced via hormones was utilized. Arginine supplementation increased 
birth weights of lambs (Lassala et al., 2010), gain in lambs (Peine et al., 2013), and peak systolic 
velocity to the CL (Saevre et al., 2011b). Recent trials have utilized a rumen-protected arginine 
product, making it feasible for producers to replicate these results (Saevre et al., 2011b). Further 
research needs to be done with both injectable Arg and rumen-protected products (both 
artificially coated and natural rumen bypass) to indicate if Arg supplementation only has effects 
in compromised situations, such as underfed or hormonally stimulated ewes. Synthetic and the 
naturally protected forms of Arg need to be investigated further to find out if replication of the 
results of the injectable Arg trials is possible. Another area that could be investigated is the 
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possibility of NO toxicity due to supplementation of Arg, looking at the negative effects on 
lambs postnatally to weaning and beyond. 
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CHAPTER 2. IMPACTS OF SUPPLEMENTAL ARGININE ON EWE REPRODUCTIVE 
PERFORMANCE 
Abstract 
In sheep, embryonic and fetal death during pregnancy can account for 25 to 50% of the 
total number of ovulations. The objective of this study was to determine the effects of injectable 
and oral arginine (Arg) supplementation provided for 14 d post-breeding on reproductive 
performance of naturally stimulated fall lambing ewes.  Two hundred ten Rambouillet ewes were 
exposed to rams equipped with marking harnesses to induce cyclicity. Upon estrus detection (d 
0) ewes were randomly assigned to one of six treatments for a 14-d treatment period: injectable 
saline (CON; n = 25), injectable alanine (IVALA; n = 20), injectable arginine (IVARG; n = 23), 
oral rumen-protected Arg (RPARG; n = 20), oral soybean meal (SBM; n = 23), or oral fishmeal 
(FM; n = 24). Daily treatments, except CON, ALA, and SBM, were formulated to provide 
supplemental Arg at approximately 30 mg/kg ewe BW.  Ewes receiving injectable treatments 
were provided 454 g/d corn post-injection. Oral supplements were ground and provided 
individually to ewes at 0800 daily. Serum/plasma samples were collected on d 0, 2, 4, 6, 8, 10, 
12, and 14 from 12 ewes per treatment to evaluate serum progesterone and amino acid 
concentrations. At lambing, birth weight, birth type, and sex were recorded. Weaning weights 
were recorded when the average age of lambs was 85 d. No differences (P ≥ 0.06) were detected 
for pregnancy and lambing rates or birth and lamb weaning weights among treatments. However, 
litter weaning weight tended (P = 0.06) and weaning rates were higher (P = 0.05) in Arg 
supplemented ewes. Plasma progesterone and serum Arg concentrations showed a treatment and 
day effect (P < 0.0001), but no treatment × day interaction (P ≥ 0.99) was observed. In contrast 
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to previous research, supplemental Arg during the first 14 d of pregnancy did not improve 
pregnancy or lambing rates, however, IVARG did positively impact weaning rates. 
Key Words: arginine, progesterone, reproduction, sheep 
Introduction 
The majority of embryonic loss in sheep occurs before d 18 of gestation (Hulet et al., 
1956; Moore et al., 1960; Quinlivan, 1966). Loss of individual embryos can occur without a 
complete loss of pregnancy, such as in the case of multiple fetuses (Rhind et al., 1980; Schrick 
and Inskeep, 1993). In sheep, it has been reported that 30% of fertilized ova are not represented 
by live births, resulting in frequent, but unrecognized loss (Bolet, 1986; Knights et al., 2003; 
Dixon et al., 2007). Current research has indicated periconceptual supplementation of Arg can 
recover these losses (Luther et al., 2009; Saevre et al., 2011a).  
Treatment with the amino acid Arg in late pregnancy increases transport of nutrients to 
the unborn lamb through the synthesis of polyamines and NO as observed by Thureen (2002), 
along with enhancements in fetal protein levels in sheep and increases in lamb birth weight (De 
Boo, 2005). Treatment of ewes with injectable Arg during maternal recognition of pregnancy 
improved pregnancy rate by 24% (Saevre et al., 2011a) and when given for 15 d post-breeding, 
increased lambing rate by 50% (Luther et al., 2009).  Previous research utilized an injectable Arg 
source, and for these results to become commercially applicable an oral form of supplemental 
Arg has to be developed. The objective of this study was to determine the effects of injectable 
and oral Arg supplementation provided 2 wk post-breeding on reproductive performance of 
naturally stimulated fall lambing ewes. Our hypothesis was injectable and supplemental Arg 
would increase pregnancy and lambing rates while decreasing postnatal lamb loss. 
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Materials and Methods 
All procedures were approved by the Animal Care and Use Committee of North Dakota 
State University (Protocol #A12038). This study was conducted at the Hettinger Research 
Extension Center in Hettinger, ND.  
Animals and Diets 
Two hundred ten multiparous Rambouillet ewes (64.7 ± 6.8 kg BW) were supplemented 
with 454 g/d of corn and exposed to 15 ram lambs to induce estrus in April of 2012. Ram lambs 
equipped with marking harnesses were introduced to ewes 12 d prior to the initiation of the 
study. Three ewes that were marked by ram lambs prior to study initiation were removed from 
the trial. Mature Rambouillet rams (n = 10) equipped with marking harnesses were introduced to 
the ewe flock on d 0. Ewes were monitored daily at 0800 to determine onset of estrus as 
indicated by breeding marks from harnessed mature rams.  Once estrus was detected, ewes were 
randomly assigned to one of six treatment groups: control (CON; n = 25), IV-alanine (IVALA; n 
= 20; Ajinomoto North America, Inc., Raleigh, NC), IV-arginine (IVARG; n = 23; Ajinomoto 
North America, Inc., Raleigh, NC), rumen-protected arginine (RPARG; n = 20), soybean meal 
(SBM; n = 23), and fishmeal (FM; n = 24) and received the treatments indoors at an ambient 
temperature of 22.2 ± 6 ° C. Ewes assigned to IVARG, IVALA, and CON were administered 
intravenous injections of Arg (30 mg  kg BW-1  d-1 of l-arginine), alanine (Ala; 30 mg  kg 
BW-1  d-1 of l-alanine), and saline daily, respectively. All ewes were injected with similar 
treatment volumes (0.100 mL  kg BW-1  d-1) of saline or their respective amino acid.  
All ewes receiving injectable treatments were individually supplemented 454 g of corn 
daily. Similar to Luther et al. (2009) and Saevre et al. (2011a), the IVARG and IVALA 
treatments were designed to provide 30 mg  kg BW-1  d-1 of metabolically available Arg or Ala; 
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respectively. Oral supplementation treatments included: RPARG (0.15 g/kg BW of rumen 
protected product mixed with ground corn), SBM (37.5:62.5 soybean meal:corn), and FM (25:75 
fishmeal:corn).  All ewes were individually supplemented 454 g/d of their respective treatments.  
The RPARG and FM treatments were designed to provide 30 mg  kg BW-1  d-1 of 
metabolically available Arg, whereas SBM was designed to be isonitrogenous to FM. During the 
entire treatment period, ewes were group fed a basal ration daily consisting of 1.88 kg alfalfa 
hay, 0.226 kg of barley haylage, and 0.023 kg trace mineral (DM basis; Table 2.1).  Ewes were 
provided water ad libitum.  
Table 2.1 describes the nutrient concentration of the dietary ingredients, including Arg %, 
rumen undegradable Arg (RUArg), microbial Arg (MicrArg), and metabolically available Arg 
(MetArg). From d 0 (estrus) until d 14, ewes individually received their assigned treatment. All 
treatments were imposed within 15 d of mature ram introduction. Ewes that were removed from 
the trial were either bred on the second cycle or died from non-treatment related problems. Feed 
samples from the basal ration were taken once every 2 d as bunks were filled. Samples of 
treatment feeds were taken each time a new ration was mixed. Common samples were compiled 
together, mixed and sent to University of Missouri, Agricultural Experiment Station Chemical 
Laboratories for analysis of Arg concentrations by AOAC Official Method 982.30 E (AOAC 
Int., 2000) similar to Brooks et al. (2011). Diets were collected and sent to Midwest 
Laboratories, Inc., Omaha, NE for analysis of DM (method 930.15; AOAC Int., 1990), ash 
(method 942.05; AOAC Int., 2010), CP (method 2001.11; AOAC Int., 2010) using a Kjeltec 
Auto 1030 Analyzer, and ADF (method 973.18; AOAC Int., 1990).  
Arginine was provided via the basal ration and through the feeds each treatment received 
(g/d; Table 2.2). Rumen undegradable Arg (RUArg), microbial Arg (MicrArg), and total Arg 
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(Total Arg) provided to the ewe for absorption each day in mg  kg BW-1  d-1 is also provided 
in Table 2.2. CON and IVALA treatments received 203.13 mg  kg BW-1  d-1 and the IVARG 
ewes receiving 233.13 mg  kg BW-1  d-1 of Total Arg. RPARG treated ewes received a total of 
250 mg  kg BW-1  d-1 Arg, as did the SBM treated ewes. Ewes supplemented with FM were 
receiving a total of 281.25 mg  kg BW-1  d-1 Arg. Each Arg supplement treatment received at 
least the target of 30 mg  kg BW-1  d-1 when compared to the CON. However, the SBM 
treatment was receiving an equal amount of Arg to the RPARG treated ewes and FM receiving 
the greatest supplementation of Arg. 
Table 2.1. Nutrient composition of feed ingredients and supplements of basal ration1 
 Diet Ingredients and Nutrient Concentration2 
Item3 Alfalfa Hay Barley Haylage Corn FM SBM RPArg 
Diet, % DM 92.0 33.0 88.0 90.0 91.0 - 
CP, % DM 18.1 12.4 9.0 64.2 46.5 - 
ADF, % DM 43.2 31.6 3.0 2.0 10.0 - 
TDN, %DM 53.3 66.5 88.0 74.0 84.0 - 
Ca, % DM 1.75 0.39 0.02 5.5 0.38 - 
P, % DM 0.22 0.38 0.3 3.15 0.71 - 
Cu, ppm 0.008 0.006 0.0004 0.0011 0.0025 - 
Arg, % 0.42 0.16 0.38 3.6 3.3 60.0 
RUArg, % 0.13 0.04 0.21 2.5 1.3 30.0 
MicrArg, % 0.35 0.43 0.57 2.4 1.2 - 
MetArg, % 0.47 0.47 0.78 5.0 2.5 - 
1Ad libitum diet provided: 90% alfalfa hay and 10% barley haylage offered (DM basis); trace mineral 
content: 16-18% Ca; 8% P; 12-14% salt; 2.5% Mg; 4% Co; 100 ppm I; 1,800 ppm Mn; 20 ppm Se; 2,000 
ppm Zn; 113,500 IU/kg Vitamin A; 11,350 IU/kg Vitamin D; and 227 IU/kg Vitamin E. 
2Corn= includes CON (IV saline), IVALA (30 mg  kg BW-1  d-1 l-alanine), and IVARG (30 mg  kg BW-1 
 d-1 l-arginine); RPARG  = 454 g/d corn and 0.15 g  kg BW-1  d-1 rumen-protected Arg; FM = 454 g/d 
25:75 FM: corn; SBM = 454 g/d 37.5:62.5 SBM: corn.   
3RUArg= rumen undegradable Arg (%Arg*RUP); MicrArg= microbial Arg [(TDN*.13)*%Arg]; MetArg= 
metabolically available Arg (RUArg + MicrArg), calculated from NRC (2007). 
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Table 2.2. Nutrients and Arginine concentration supplied from treatment diets and basal ration1 
 Diet Ingredients and Arginine Concentration (DM basis)2 
Item CON IVALA IVARG RPARG SBM FM 
Diet, g/d 2,505 2,505 2,505 2,509 2,506 2,515 
CP 404 404 404 404 462 460 
ADF 896 896 896 896 906 895 
TDN 1504 1504 1504 1504 1500 1491 
Ca 34 34 34 34 34 39 
P 6 6 6 6 6 9 
Cu, ppm 0.02 0.02 0.02 0.02 0.02 0.02 
Total Arg3, mg  kg BW-1  d-1 203 203 233 250 250 282 
Arg4 156 156 156 250 219 203 
RUArg4 47 47 77 94 78 94 
MicrArg5 156 156 156 156 172 188 
1CON= IV saline; IVALA= 30 mg  kg BW-1  d-1 l-alanine; IVARG= 30 mg  kg BW-1  d-1 l-arginine; RPARG= 
454 g/d corn and 0.15 g  kg BW-1  d-1 rumen-protected Arg; FM = 454 g/d 25:75 FM: corn; SBM = 454 g/d 
37.5:62.5 SBM: corn. 
2SBM and FM ingredients calculated based on O’Mara et al. (1997) values; ground corn calculation (component of 
each treatment) based on NRC (2007). 
3Total Arg= total Arg provided for absorption (RUArg + MicrArg). 
4Arg= total Arg provided by the diet. 
4RUArg= rumen undegradable Arg (%Arg*RUP), calculated from NRC (2007). 
5MicrArg= microbial Arg [(TDN*0.13)*%Arg)], calculated from NRC (2007). 
 
Ewes were allowed to graze and checked daily at approximately d 55 of gestation. At 
approximately 130 d of pregnancy, ewes were brought to the Hettinger Research Extension 
Center lambing barn and bunk fed in pens of 15 a total mixed ration of 0.242 kg ground hay, 
0.607 kg barley grain, 0.773 kg barley haylage, and 0.023 kg of trace mineral (DM basis; Table 
2.3). Lambs were fed a grower pellet ad libitum which was 38% crude protein, 1% crude fat, 4-
5% Ca, 0.6% P, 3.5-4.5% salt, 3.0 ppm Se, 52,800 IU/kg Vitamin A, 5280 IU/kg Vitamin D, and 
132 IU/kg Vitamin E. The grower pellet was also medicated with chlortetracycline at a rate of 
4.4 g/kg of feed. Lambs were weaned at approximately 85 d of age. 
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Table 2.3. Nutrient composition of ration ingredients in late gestation and lactation1  
 Diet Ingredients and Nutrient Concentration2 
Item Ground Hay Barley Haylage Barley Grain Total 
Diet, % DM 85.9 26.9 89.2 95.7 
CP, % DM 15.0 18.3 13.6 26.0 
ADF, % DM 39.6 28.2 6.2 35.2 
TDN, %DM 63.1 68.7 87.2 121.0 
Ca, % DM 1.38 0.80 0.08 1.4 
P, % DM 0.18 0.36 0.50 0.81 
Cu, ppm 6.0 5.0 8.0 19.0 
1Ad libitum diet 0.242 kg ground hay, 0.773 kg barley haylage, 0.607 kg barley grain, and 0.023 kg 
of trace mineral (DM basis). 
2Trace mineral content: 16-18% Ca; 8% P; 12-14% salt; 2.5% Mg; 4% Co; 100 ppm I; 1,800 ppm 
Mn; 20 ppm Se; 2,000 ppm Zn; 113,500 IU/kg Vitamin A; 11,350 IU/kg Vitamin D; and 227 IU/kg 
Vitamin E. 
 
     
Sample collection 
Blood samples were collected via jugular venipuncture using a 20 G × 2.54 cm needle 
into 10 mL serum/plasma tubes (BD Vacutainer Serum, Becton, Dickinson and Company, 
Franklin Lakes, NJ; BD Short Bevel Needles, #305178, Becton, Dickinson and Company, 
Franklin Lakes, NJ) on d 0, 2, 4, 6, 8, 10, 12, and 14 from 12 random ewes per treatment prior to 
administration of treatment at 0800 and immediately placed on ice. Samples were then 
centrifuged at 4° C for 30 min at 1500 × g and serum/plasma was transferred into plastic 2.0 mL 
mirocentrifuge tubes and frozen at -20° C until assayed. Serum samples were assayed for 
concentrations of circulating progesterone using IMMULITE 1000 (Siemens Healthcare 
Diagnostics; Galbreath et al., 2008). Serum samples were assayed (n=5) for amino acid 
concentrations similarly to Lekatz et al. (2011). At lambing, birth weight, birth type, and sex 
were collected. Weaning weights were collected when the average lamb age was 85 ± 15 d.  
Statistical analyses 
Pregnancy, prolificacy, lambing rates, and weaning rates were analyzed using the 
GLIMMIX procedure of SAS (SAS Inst. Inc., Cary, NC). Birth BW, weaning BW, serum amino 
acid, and plasma progesterone concentrations were analyzed using the MXED procedure of SAS. 
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When analyzing weaning weights, the model included either birth type or weaning rate. The 
model included fixed effects of dietary treatment, d, and treatment × d. Significance was 
determined at P ≤ 0.05. To partition treatment and d effects and treatment × d interactions, LS 
means and PDiffs were utilized (P ≤ 0.05). 
Results 
No differences (P ≥ 0.39; Table 2.4) were detected for pregnancy, prolificacy, or lambing 
rates among treatments. Weaning rate was greatest for IVARG treated ewes (P = 0.05) and least 
for RPARG ewes (P = 0.05). There were also no differences (P ≥ 0.21) for lamb birth or adjusted 
weaning BW among treatments; however, when weaning weights were analyzed without number 
of lambs born in the model, there was a tendency (P = 0.06) for lambs born to IVARG ewes to 
have the largest weaning BW while lambs born to RPARG ewes had the smallest weaning BW.  
There was a treatment and a day effect (P < 0.0001; P = 0.0004; respectively) detected in 
serum Arg concentrations, which increased from d 0 through d 14 with the exception of d 6 
being less than d 4 (P ≤ 0.05). The treatments exhibiting the highest (P < 0.0001) serum 
concentrations of Arg were IVALA, IVARG, and SBM with RPARG having the highest 
(202.13, 188.57, 206.92, 257.5 ± 24.9 mol/L; respectively). Serum concentrations of citrulline 
(Cit) were highest (P <0.0001) for IVALA and IVARG treatments, with SBM being similar to 
IVARG (233.72, 214.70, and 204.97 ± 7.8 mol/L; respectively); however, there was no d effect 
for Cit (P=0.96). Ornithine (Orn) serum concentrations were lower (P <0.0001) in CON and 
IVARG treated ewes (52.13 and 47.50 mol/L, respectively), but exhibited no d effect (P=0.96). 
Two treatment × d interactions were observed for serum amino acid concentrations: 
hydroxylysine-2 (Hyl2; P=0.0007) and -amino-N-butyric acid (GABA; P= 0.0002). 0.04), with 
concentrations tending to decrease over time, although d 0 and 4 had no reported values. 
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Interestingly, GABA concentrations were also increased (P < 0.0001) for ewes receiving FM 
(9.88 ± 0.4 mol/L) and also exhibited a d effect (P = 0.04) with concentrations tending to 
increase over the 14 d period. There were no other treatment × d interactions detected (P ≥ 0.77) 
for serum amino acid concentrations for treatments (Table 2.5). The complete amino acid 
concentration profile is presented in the Appendix.  
There was no treatment × day interaction (P ≥ 0.99; Table 2.4) detected in plasma 
progesterone concentrations; however, there was a treatment (P < 0.0001) and a d effect (P = 
0.0004; Figure 2.1), with progesterone concentrations increasing from d 0 through d 14 with the 
exception of d 8 being greater than d 10. The CON, IVALA, and RPARG ewes had similar 
levels of progesterone (2.79, 2.74, and 2.74; respectively); however, progesterone concentrations 
were decreased in ewes given FM, SBM, and the IVARG treatments. More interestingly, the 
RPARG treated ewes had higher (P < 0.0001) progesterone concentrations than the FM, SBM, 
and IVARG ewes. 
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Figure 2.1. Effect of day on ewe plasma progesterone concentrations. 
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Table 2.4. Effects of daily injection of saline, L-alanine, L-arginine or oral supplementation of L-arginine 2 wk post-breeding on ewe 
performance 
 Treatment1   
Item3 CON IVALA IVARG RPARG FM SBM SEM P-value2 
Pregnancy, % 88 90 88 86 88 83 11.6 0.99 
Prolificacy   1.32   1.21 1.43 1.17 1.18 1.25 0.19 0.39 
Lambing Rate   1.16   1.10 1.25 1.00 1.04 1.04 0.36 0.72 
Weaning Rate   1.09bc   0.95abc 1.29c 0.72a 1.00abc 0.86ab 0.12 0.05 
Progesterone, ng/mL4   2.79c   2.74c 2.38ab 2.74c 2.10a 2.43b 0.42 <0.0001 
1CON = IV saline; IVALA = 30 mg  kg BW-1  d-1 L-alanine; IVARG = 30 mg  kg BW-1  d-1 L-arginine; RPARG  = 454 g/d corn and 0.15 g  kg BW-1  d-1 
rumen-protected Arg; FM = 454 g/d 25:75 FM: corn; SBM = 454 g/d 37.5:62.5 SBM: corn. 
2P-value for the overall F test of treatment (n = 25, 20, 23, 20, 24, and 23 for CON, IVALA, IVARG, RPARG, FM, and SBM respectively). 
3Pregnancy = percent pregnant per ewe treated; Prolificacy= lambs per ewe lambed; Lambing rate = lambs per ewe treated; Weaning rate= lambs weaned per ewe 
lambing. 
4Progesterone: n=12 per treatment. 
a,b,c Means with different superscripts differ (P ≤ 0.05) within each row; LS means were separated when P-value were ≤ 0.05 for treatment. 
 
Table 2.5. Effects of daily injection of saline, L-alanine, L-arginine or oral supplementation of L-arginine 2 wk post-breeding on lamb 
performance 
 Treatment1   
Item CON IVALA IVARG RPARG FM SBM SEM P-value2 
Birth BW, kg 5.4 5.4 5.2 5.3 5.3 5.2 0.24 0.57 
Weaning BW, kg3 24.6 19.3 26.1 15.4 20.8 18.0 2.69 0.06 
AdjWeaning BW, kg4 26.7 22.8 26.9 19.3 24.5 21.1 3.04 0.21 
1CON = IV saline; IVALA = 30 mg  kg BW-1  d-1 L-alanine; IVARG = 30 mg  kg BW-1  d-1 L-arginine; RPARG  = 454 g/d corn and 0.15 g  kg BW-1  d-1 
rumen-protected Arg; FM = 454 g/d 25:75 FM: corn; SBM = 454 g/d 37.5:62.5 SBM: corn. 
2P-value for the overall F test of treatment (n = 25, 20, 23, 20, 24, and 23 for CON, IVALA, IVARG, RPARG, FM, and SBM respectively). 
3Weaning BW= litter weight or total ewe productivity. 
4AdjWeaning BW= litter weight or total ewe productivity with number of lambs born in the model, (P-value for birth type ≤ 0.001). 
a,b,c Means with different superscripts differ (P ≤ 0.05) within each row; LS means were separated when P-value were ≤ 0.05 for treatment. 
 
 37 
 
 
Table 2.6. Effects of daily injection of saline, L-alanine and L-arginine or oral 
supplementation of rumen-protected Arg, FM, SBM 2 wk post-breeding on ewe serum 
Ala, Arg, Cit, Orn, GABA, and Hyl2 concentrations 
 Treatment1  P-value2 
Item, 
mol/L3 
CON IVALA IVARG RPAR
G 
FM SBM SEM Trt Day 
Arg 174.4c 202.1ab 188.6bc 
172.6c 
214.7bc 
192.3ad 
47.5c 
63.8bd 
257.5a 
211.0b 
5.0ae 
5.8e 
0.77b 
0.64b 
161.5c 206.9a 24.9 <0.0001 0.0004 
Cit 189.2ad 233.7b 183.1d 205.0ac 7.8 <0.0001 0.96 
Orn 52.1ac 58.8ad 66.7bd 66.4bd 2.9 <0.0001 0.94 
Ala 258.4a 241.8acd 230.8bc 229.3bd 7.5 <0.0001 0.003 
GABA 5.1ae 3.9d 9.9b 4.7ad 0.4 <0.0001 0.04 
Hyl2 - 0.77b 1.19a 0.74b 0.05 <0.0001 0.04 
1CON = IV saline; IVALA = 30 mg  kg BW-1  d-1 L-alanine; IVARG = 30 mg  kg BW-1  d-1 L-arginine; 
RPARG  = 454 g/d corn and 0.15 g  kg BW-1  d-1 rumen-protected Arg; FM = 454 g/d 25:75 FM: corn; SBM 
= 454 g/d 37.5:62.5 SBM: corn. 
2P-value for the overall F test of treatment (n = 5, 5, 5, 5, 5, and 5 for CON, IVALA, IVARG, RPARG, FM, 
and SBM respectively). LS means were utilized to separate treatments differences when P ≤ 0.05. 
3GABA= gamma-amino-N-butyric acid and Hyl2= hydroxylysine 2. 
a,b,c Means with different superscripts differ (P ≤ 0.05) within each row; LS means were separated when P-value 
were ≤ 0.05 for treatment. 
 
Discussion 
 
The most important factor effecting success of most commercial sheep operations is 
reproductive efficiency (Lupton, 1998). New advancements in technology offer the possibility 
for significant improvements in efficiency of lamb production. With a volatile market 
continuing to potentially decrease profit margins, an increased emphasis, by producers and 
scientists alike, has been placed on maximizing lamb profitability.  
Arginine is important for many biological functions, including synthesis of NO (Gouge 
et al., 1998; Manser et al., 2004). It has been hypothesized that treating ewes with Arg at, or 
slightly before, the time of maternal recognition of pregnancy may enhance the survival of the 
embryo during early embryogenesis (Luther et al., 2009). This is likely accomplished through 
the role Arg plays in polyamine and NO synthesis. Gestating sows supplemented with arginine 
achieved a 22% increase in live piglets born (11.4 vs. 9.4, P < 0.03, respectively; Mateo et al., 
2007). Furthermore, pregnant rats supplemented with 1.3% Arginine-HCl throughout pregnancy 
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or between d 1 and 7 of gestation had increased embryonic survival and litter size by 30% 
(Zeng et al., 2008). 
Pregnancy rates were not influenced through injectable or oral treatments in our study. 
Similarly, Luther et al., (2009) observed no differences in pregnancy rates for supplementation 
with injectable Arg from d 0 through d 14. In contrast, pregnancy rates were greater in ewes 
supplemented with injectable Arg from d 9 through 14 post-breeding (Saevre et al., 2011a). In 
the aforementioned studies (Luther et al., 2009; Saevre et al., 2011a), pregnancy rates ranged 
from 45-55%, whereas, pregnancy rates were approximately 88% for the current trial. The 
differences in pregnancy rates between these studies could be due to a difference in estrus 
synchronization techniques utilized. Ewes in the previous two studies were synchronized 
artificially with a controlled internal drug release inserts and an injection of PG600 (containing 
400 IU of equine chorionic gonadotropin and 200 IU of human chorionic gonadotropin); 
whereas, the ewes in our study were naturally synchronized using ram exposure. 
In the present study, only 1.5% of ewes displayed estrus prior to the start of the trial, 
indicating that most of the flock was in a period of anestrus before ram introduction. Gonzalez-
Bulnes et al. (2005) gives evidence that progestagens, when compared with prostaglandin type 
products, might have negative effects on the functionality of ovulatory follicles. These follicles 
showed deficiencies in estradiol secretion during the preovulatory phase, which could prevent 
the oocyte from developing into a viable embryo (Gonzalez-Bulnes et al., 2005). Leoni et al. 
(2001) reported that ewes given superovulatory treatment with eCG/FSH had increased ovarian 
responses compared to FSH alone; however, the embryos showed a reduction in viability rates. 
In hamsters, embryos harvested from PMSG treated females and implanted into recipients 
showed a two-fold decrease in viability post-transfer when compared to non-stimulated 
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hamsters (McKiernan and Bavister, 1998). Although the aforementioned trials were all 
performed in embryo transfer trials, the results show that artificial usage of hormones can 
severely affect the viability of the embryos ovulating. 
Prolificacy was not influenced through injectable or oral treatments in the present study. 
Similarly, Saevre et al. (2011a) reported no influence on prolificacy through injectable L-Arg. 
However, Luther et al., (2009) demonstrated differences in prolificacy with 1.6 lambs born per 
ewe treated with injectable Arg vs. 1.1 for the control ewes. We observed an average of 1.1 
lambs born per ewe. Ovulation rates in out-of-season ewes have been shown to decrease by at 
least 15% when compared with in-season ewes (Glimp, 1971). Lunstra and Christenson (1981) 
demonstrated with administration of progesterone and PMSG, ovulation rates of out-of season 
ewes could be increased by 50%. Due to these varying results, more research is needed on the 
use of exogenous hormones in anestrous ewes and the effects of lambing rates for in-season and 
out-of-season ewes. It is possible that with hormonal induction to estrus, ewes might have 
increased ovulation rates. However, the oocytes can potentially be less viable. Ewes naturally 
induced to estrus, whether through light manipulation or ram introduction, have lower rates of 
ovulation, but the oocytes are healthier with increased viability. With limited research 
comparing naturally stimulated ewe’s embryo quality to those artificially stimulated, it is 
difficult to make a definitive conclusion regarding this hypothesis. Arginine supplementation 
could be recovering these less viable embryos when in these compromised situations, but have 
no effect when embryos are not compromised in a “natural” model. 
There were also no differences in adjusted weaning BW for our study and we are 
unaware of any prior Arg research that has reported weaning data. However, there was a 
tendency, when number of lambs born was not considered, for weaning weights IVARG treated 
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lambs to be increased. However, weaning rates for RPARG treated ewes were reduced when 
compared to the other treatments, while IVARG ewes had the greatest weaning rates. With the 
previous conclusion that Arg supplementation might possibly be recovering less viable 
embryos, is it possible that these lambs were born weak and not able to reach weaning? 
However, this is perplexing and quite speculative since the IVARG treated ewes tended to have 
the greatest weaning weights, and the RPARG lambs weights were still lowest. Additionally, 
the RPARG treatment could be providing too much Arg and up regulating NO synthesis, and 
therefore causing a toxicity to the lambs and compromising their future health and performance 
(Buhimschi et al., 1998). More research needs to be performed to address why these lambs 
underperformed. 
Interestingly, Hyl2 concentrations were highest in ewes receiving FM, since FM is an 
excellent source of Hyl2. Although data for this amino acid is not commonly reported, it is a 
component in type III collagen and used for the structural components of vascularity. Therefore, 
increased levels of Hyl2 could be an indication of increased vascular growth occurring in FM 
supplemented ewes. Concentrations of GABA were also elevated in ewes receiving FM, which 
could have impacts on polyamine synthesis (McCann et al., 1979). McCann et al. (1979) 
reported that GABA, when added to rat hepatoma cells at the time of induction of cell 
proliferation, increased levels of ornithine decarboxylase (ODC) up to two- to three-fold when 
compared to control cells. The increase in ODC is also reflected by increases in intracellular 
putrescine levels, while spermidine and spermine were unchanged.  
McCann et al. (1979) reported that GABAs stabilizing effect on ODC could be 
important in certain types of cells for the regulation of polyamine biosynthesis, which is 
important for placental development (Wu and Morris, 1998). Interestingly, serum levels of Arg 
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were only elevated in ewes receiving RPARG, IVARG, IVALA, and SBM, with only one of the 
supplemental Arg treatments succeeding in elevating serum levels. Saevre et al. (2011a) 
observed an increased level of serum Arg concentrations in ewes that received IVArg when 
compared to CON ewes’; however, Saevre et al. (2011b) reported that RPARG was provided at 
much higher concentrations of the diet and did increase serum Arg levels on d 11 and 12 of 
pregnancy when provided at 360 mg/kg BW compared to ewes on the CON diet, 90 mg/kg BW, 
and 180 mg/kg BW. 
Citrulline concentrations were increased in IVALA and IVARG treated ewes, with SBM 
fed ewes being similar to IVARG levels. In contrast, Saevre et al. (2011a, b) reported no effects 
on Cit levels. A lack of increased levels of Cit by Saevre et al. (2011a, b) could be due to timing 
of serum samples being taken, since Cit is utilized for production of Arg and in circulation for a 
short period of time before being extracted from circulation by the kidney (Wu and Morris, 
1998). It could also be due to an increased need for Arg synthesis, therefore an increase in 
production of Cit; however, this does not agree with the results from our current trial. It is 
possible that the increased Cit levels in IVARG, IVALA, and SBM treated ewes were causing 
the increase in serum Arg levels which were increased in these same treatments, since Cit is a 
precursor in the synthesis of Arg. However, further research would be needed to elucidate 
possible factors in the resulting concentration.  
Ornithine concentrations were decreased in CON and IVARG ewes, which is interesting 
since increased Cit levels were observed in IVARG ewes and Orn is a precursor to Cit in the 
synthesis of Arg. However, this could be due to timing in blood sampling or possibly the 
ammonia pathway to synthesize Cit was utilized via carabmoyl-phosphate synthase I versus the 
Orn pathway (Wu and Morris, 1998).  Treatments exhibiting increased Orn concentrations in 
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serum include: IVALA, RPARG, FM, and SBM. With the exception of IVALA, this increase in 
Orn concentration could be the result of a difference in the protein supply via feedstuffs. 
In order for Arg supplementation to become more commercially applicable, an oral form 
of supplemental Arg should be developed. However, the results delivered thus far from oral 
supplementation have been in compromised maternal statuses and the results were equal to that 
of the control ewes. More research needs to be performed comparing challenged maternal 
statuses to see the true results of supplementation of Arg. The objective of this study was to 
determine the effects of injectable and oral Arg supplementation provided 2 wk post-breeding 
on reproductive performance of naturally stimulated fall lambing ewes. Our hypothesis was that 
supplemental Arg would increase pregnancy and lambing rates while decreasing postnatal lamb 
loss. In the current study, utilizing ewes synchronized for estrous through ram exposure for fall 
lambing, we reject the hypothesis that supplemental Arg will increase pregnancy rates and 
lambing rates; however, injectable Arg did increase weaning rates. 
Implications 
Although some previous research suggests that embryonic survival in sheep can be 
enhanced when ewes are supplemented with Arg, we did not detect any improvements in 
reproductive performance or lamb growth in ewes supplemented with injectable, non-rumen-
protected, or rumen-protected forms of Arg; with the exception of IVARG improving weaning 
rates. Rumen-protected Arg should be investigated and examined to determine why weaning 
rates were decreased when supplemented to ewes and also why these sources did not yield the 
expected results. We also feel further research is warranted to determine rate of reproductive 
loss from different methods of non-seasonal estrus induction and the ability of supplemental 
Arg to recover these losses.  
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APPENDIX. SERUM AMINO ACID CONCENTRATIONS 
 
Table A.1.  Effects of daily injection of saline, l-alanine and l-arginine or oral supplementation 
of rumen-protected Arg, FM, SBM 2 wk post-breeding on ewe serum amino acid 
concentrations 
 Treatment1  P-value2 
Item, mol/L3 CON IVALA IVARG RPARG FM SBM SEM Trt Day 
β-Ala 5.05ab 5.43b 5.22b 4.71a 5.18b 5.45b 0.16 0.013 0.29 
Thr 106.18ac 109.14a 101.88ac 83.34b 93.14bc 102.02ac 5.02 0.004 0.32 
AADA 5.96a 4.54bc 5.36a 4.72c 4.53bc 4.00b 0.22 <0.0001 0.87 
Pro 101.61ac 106.14a 106.60a 87.06b 86.68b 98.72c 2.71 <0.0001 0.19 
AABA 13.46a 12.56ab 15.36c 12.30b 9.45d 13.63a 0.41 <0.0001 <0.0001 
Cys 5.47a 4.88abc 5.17abc 4.43bc 4.44bc 4.67abc 0.29 0.09 0.97 
Lys 123.96ac 105.28bcd 120.51ad 110.80abd 113.96abd 108.71d 4.96 0.08 0.008 
Tyr 59.08a 68.66b 69.48b 52.39a 54.72a 52.71a 2.47 <0.0001 0.009 
Met 19.67ac 19.92ac 20.82c 16.62b 18.77a 18.59a 0.64 0.0002 0.36 
Val 214.97ac 233.87bc 243.86b 200.89a 202.45a 226.22bc 8.37 0.0011 0.88 
Ile 82.54abc 83.95cd 91.20d 76.15bc 75.61b 85.38da 3.04 0.003 0.69 
Leu 122.88ad 129.65ac 137.18c 111.79bd 111.44b 121.41abd 4.09 <0.0001 0.87 
Phe 54.08a 59.26b 59.90b 49.73a 44.45c 50.38a 1.69 <0.0001 0.03 
Trp 39.04ac 44.63b 46.27b 37.63ac 35.65a 40.30c 1.40 <0.0001 0.03 
His 58.49a 58.48ac 57.43ac 48.73b 46.15b 56.67ac 1.37 <0.0001 0.62 
Asn 63.91a 60.13a 58.35a 47.93b 47.04b 57.54a 2.42 <0.0001 0.02 
3MH 26.93a 21.84ac 23.10a 18.69bc 14.06b 21.49ac 1.96 <0.0001 0.05 
Tau 53.24a 74.97b 66.68b 53.38a 68.27b 73.65b 4.01 <0.0001 0.51 
1MH 63.40a 68.01acd 72.07bd 64.18a 59.65a 61.33a 2.72a 0.02 0.70 
Ser 83.36a 86.85a 99.58c 73.26d 57.55b 84.27a 2.80 <0.0001 0.52 
Gln 231.24a 223.01ac 249.12d 199.46e 223.01b 213.28ce 6.06 <0.0001 0.27 
Car 26.94a 21.55bc 22.69b 20.27b 16.89c 18.35c 1.29 <0.0001 0.98 
Gly 592.57a 644.83c 654.62a 485.71bc 415.97b 571.90bc 14.39 <0.0001 0.72 
Ans 11.98a 8.29c 10.53c 7.08d 5.58b 6.78a 0.57 <0.0001 0.50 
EA 4.43a 5.01a 4.87a 4.37a 3.39b 4.41a 0.235 <0.0001 0.11 
Asp 14.70a 13.35c 14.32d 14.11b 12.09b 11.67b 0.54 0.0002 0.25 
HyPro 15.26a 18.92b 19.23b 13.60c 15.28a 16.00a 0.58 <0.0001 0.90 
Sar 3.83a 4.19c 4.56d 3.25b 2.99b 3.27b 0.11 <0.0001 0.12 
Glu 88.69a 78.52b 85.19ad 80.35bde 84.70ace 81.46bcd 2.12 0.01 0.55 
1CON = IV saline; IVALA = 30 mg  kg BW-1  d-1 l-alanine; IVARG = 30 mg  kg BW-1  d-1 l-arginine; RPARG  
= 454 g/d corn and 0.15 g  kg BW-1  d-1 rumen-protected Arg; FM = 454 g/d 25:75 FM: corn; SBM = 454 g/d 
37.5:62.5 SBM: corn. 
2P-value for the overall F test of treatment (n = 5, 5, 5, 5, 5, and 5 for CON, IVALA, IVARG, RPARG, FM, and 
SBM respectively). LS means were utilized to separate treatments differences when P ≤ 0.05. 
3GABA= gamma-amino-N-butyric acid, AADA= alpha-amino-adipic acid, Hyl2= hydroxylysine 2, AABA= alpha-
amino-N-butyric acid, 3MH= 3-methylhistidine, 1MH= 1-methylhistidine, Ans= anserine, EA= ethanolamine, 
HyPro= hydroxyproline. 
a,b,c Means with different superscripts differ (P ≤ 0.05) within each row; LS means were separated when P-value 
were ≤ 0.05 for treatment. 
 
